Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer

Spring, LM; Clark, SL; Li, TY; Goel, S; Tayob, N; Viscosi, E; Abraham, E; Juric, D; Isakoff, SJ; Mayer, E; Moy, B; Supko, JG; Tolaney, SM; Bardia, A

Bardia, A (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02115 USA.

NPJ BREAST CANCER, 2021; 7 (1):

Abstract

Patients with HER2+ metastatic breast cancer are often treated with a multitude of therapies in the metastatic setting, and additional strategies to p......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索